Safety and Effectiveness of the PXL-Platinum 330 System

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Corneal Ectasia, Keratoconus, Pellucid Marginal Corneal Degeneration

In brief

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

Key facts

Study ID
NCT04401865
Run by
Colorado Eye Consultants/Cornea Consultants of Colorado
People needed
300
Starts
2020-06-01
Expected to finish
2023-06-30
Last updated by the study team
2022-01-25

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.